T0	Interventions 34 46	mecamylamine
T1	Interventions 136 182	nicotinic acetylcholine receptor (nAChR) agent
T2	Interventions 337 356	METHOD Mecamylamine
T3	Interventions 557 567	to placebo
T4	Interventions 574 589	or mecamylamine
T5	Interventions 838 866	(10 mecamylamine, 8 placebo)
T6	Interventions 988 998	of placebo
T7	Interventions 1379 1389	on placebo
T8	Interventions 1745 1767	continued mecamylamine
T9	Interventions 1790 1813	CONCLUSION Mecamylamine
T10	Interventions 2024 2072	specific α4β2 nAChR agonist, such as varenicline